1 / 34

Chapter 21

Chapter 21. Congenital and Genetic Disorders. Genetic Control. Genetic information stored in chromosomes 23 pairs in humans 22 pairs—autosomes One pair of sex chromosomes — XX or XY Karyotype Visual representation of chromosomes arranged in order of size

Pat_Xavi
Download Presentation

Chapter 21

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 21 Congenital and Genetic Disorders

  2. Genetic Control • Genetic information stored in chromosomes • 23 pairs in humans • 22 pairs—autosomes • One pair of sex chromosomes—XX or XY • Karyotype • Visual representation of chromosomes arranged in order of size • Used in diagnosis of chromosomal disorders

  3. Examples of Karyotypes

  4. Genetic Control (Cont.) • Genotype • Actual genetic information carried by the individual • All cells except the gametes of an individual have the same genotype. • Not all genes are expressed in all cells. • Phenotype • Expression of genes • Appearance of the individual’s characteristics

  5. Congenital Disorders • Disorders present at birth • Include inherited or developmental disorders • Inherited disorders may be caused by • Single-gene expression • Chromosomal defect • Polygenic expression • Single-gene disorders • Trait controlled by one set of alleles • Transmitted to subsequent generations

  6. Congenital Disorders (Cont.) • Chromosomal anomalies • Usually caused by an error during meiosis • Nondisjunction • Translocation

  7. Congenital Disorders (Cont.) • Teratogenic agents • Agents that cause damage during embryonic or fetal development • Multifactorial disorders • Large number of disorders are of this type • Often have pattern of familial inheritance • Environmental component

  8. Congenital Disorders (Cont.) • Other congenital or developmental disorders • Result from premature birth • Difficult labor and delivery • Cerebral palsy is an example.

  9. Single-Gene Disorders • Classified by inheritance patterns • Recessive • Dominant • X-linked recessive • Single gene controls a specific function • Example: color blindness • May have systemic effects • Examples: cystic fibrosis, Tay-Sachs disease, phenylketonuria (PKU)

  10. Single-Gene Disorders • Autosomal dominant disorders • Adult polycystic kidney disease • Huntington’s chorea • Familial hypercholesterolemia • Marfan’s syndrome

  11. Autosomal Recessive Disorders • Both parents must pass on the allele for disorder. • Parents may be heterozygous and unaffected; they are termed carriers. • Parents may be homozygous and affected. • Male and female children are affected equally. • Homozygous recessive child has the disorder. • Heterozygous child • No clinical signs of disease • Child is a carrier

  12. Autosomal Recessive Disorders (Punnett Square) (Cont.)

  13. Autosomal Recessive Disorders (Cont.) • Cystic fibrosis • PKU • Tay-Sachs disease

  14. Autosomal Dominant Disorders • Inheritance of one allele causes disorder; only one parent needs to carry allele • No carriers • Unaffected persons do not transmit the disorder. • Some conditions become evident later in life. • Allele for disorder may have been passed on to next generation before diagnosis of disease in parent. • Termed delayed lethal genotype

  15. Autosomal Dominant Disorders (Punnett Square) (Cont.)

  16. Autosomal Dominant Disorders (Cont.) • Adult polycystic kidney disease • Huntington’s disease • Familial hypercholesterolemia • Marfan’s syndrome

  17. X-Linked Disorders • Recessive • Allele carried on the X chromosome but not the Y chromosome • Manifested in heterozygous males lacking the matching unaffected gene on the Y chromosome • Heterozygous females are carriers. • Homozygous recessive females may be affected. • Inheritance may appear to skip generations. • Examples: • Duchenne muscular dystrophy • Classic hemophilia

  18. X-Linked Recessive Disorder(Punnett Square)

  19. X-Linked Disorders (Cont.) • Dominant disorder • Heterozygous males and females affected • Reduced penetrance in females • Fragile X syndrome is an example. • Most common genetic cause of cognitive deficits • Effects are variable and related to the extent of mutation of the allele.

  20. Single-Gene Disorders • Autosomal recessive disorders • Cystic fibrosis • Phenylketonuria • Sickle cell anemia • Tay-Sachs disease • X-linked dominant disorders • Fragile X syndrome • X-linked recessive disorders • Color blindness • Duchenne muscular dystrophy • Hemophilia A

  21. Chromosomal Disorders • Down syndrome • Trisomy 21 • May be caused by nondisjunction or translocation • Turner syndrome XO • Affects females • Short stature • Infertility • Klinefelter syndrome XXY • Extra X chromosome is present • Infertility

  22. Down Syndrome • Trisomy 21 • Common chromosomal disorder • Affects physical and mental development • Risk increases with maternal age • Triple or quad screening test and/or first-trimester screening test (ultrasound + maternal blood screening) • May be used to screen for risk of Down syndrome • Amniocentesis or chorionic villi sampling used to confirm the disorder prior to birth

  23. Characteristics of Down Syndrome • Small head, round face, flat facial profile • Slanted eyes and epicanthic fold • Large tongue, high-arched palate • Small hands, single palmar crease • Short stature • Muscles tend to be hypotonic; loose joints • Delayed developmental stages • Cognitive impairment ranges from mild to major • Delayed or incomplete sexual development • Males infertile • Females have lower rate of conception

  24. Down Syndrome (Cont.)

  25. Down Syndrome (Cont.)

  26. Multifactorial Disorders • Genetic influences combined with environmental factors • Examples: • Cleft palate • Congenital hip dislocation • Congenital heart disease • Type 2 diabetes mellitus

  27. Developmental Disorders • Exposure to drugs, chemicals, or radiation during childbearing years • TORCH—acronym for maternal infections that can result in anomalies • Routine prenatal screening tests • Exposure to known teratogens in the first 2 months of development • Impairs organogenesis

  28. Effects of Teratogens During Pregnancy

  29. Diagnostic Tools • Testing may be available. • Prior to conception • During first trimester of pregnancy • In newborn • Testing recommended for: • Family history of a specific disease • Previous birth to child with abnormality • Ethnic groups with high risk for specific disease • Pregnant women > 35 years of age

  30. Diagnostic Tools (Cont.) • Blood tests of pregnant woman • Alpha-fetoprotein testing • In utero testing • Amniocentesis • Chorionic villi assay • Neonatal testing • Excreted metabolites (e.g., PKU) • Blood testing

  31. Genetic Engineering • Isolating, copying, and transplanting genes • In microorganisms, plants, animals, humans • Used in agriculture to produce transgenic or genetically modified foods • Ultimate goal • Insert normally functioning allele to prevent disease • Technically possible but clinical trials have not been uniformly successful

  32. Gene Therapy • Identifies gene and protein responsible for condition • Determines how gene expression is controlled • Produces drug that will inhibit gene expression • Research focus on cancer growth promoters has resulted in these types of drugs.

  33. Genetic Screening and DNA Testing • Screening at-risk populations for a specific allele • Costly • Concerns regarding privacy and access to information • DNA testing to identify individuals for paternity or forensic purposes • Legislation has been drafted in the United States to protect the genetic rights of individuals. • Health care • Employment • Insurance

  34. Designer Drugs • Proteomics research • Gene expression • Characterization of proteins significant in the metabolic pathway for expression of a particular allele • Some designer drugs act differently in genetically different individuals. • This research will help develop drugs tailored to an individual’s genotype. • Reduce unwanted side effects of commonly used medications

More Related